Advertisement
Research Article

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination

  • Ann S. Goldman mail,

    sphasg@gwumc.edu

    Affiliation: Department of Epidemiology and Biostatistics, The George Washington School of Public Health and Health Services, Washington, DC, United States of America

    X
  • Victoria H. Guisinger,

    Affiliation: Lymphatic Filariasis Support Center, Emory University, Atlanta, Georgia, United States of America

    X
  • Moses Aikins,

    Affiliation: Health Research Unit, Ghana Health Service, Accra, Ghana

    X
  • Maria Lourdes E. Amarillo,

    Affiliation: Department of Clinical Epidemiology, College of Medicine, University of the Philippines, Manila, The Philippines

    X
  • Vicente Y. Belizario,

    Affiliation: Department of Parasitology, College of Public Health, University of the Philippines, Manila, The Philippines

    X
  • Bertha Garshong,

    Affiliation: Health Research Unit, Ghana Health Service, Accra, Ghana

    X
  • John Gyapong,

    Affiliation: Health Research Unit, Ghana Health Service, Accra, Ghana

    X
  • Conrad Kabali,

    Affiliation: National Institute of Medical Research, Dar es Salaam, Tanzania

    X
  • Hussein A. Kamal,

    Affiliation: Ministry of Health & Population, Cairo, Egypt

    X
  • Sanjat Kanjilal,

    Affiliation: Lymphatic Filariasis Support Center, Emory University, Atlanta, Georgia, United States of America

    X
  • Dominique Kyelem,

    Affiliation: Lymphatic Filariasis Program, Ministry of Health, Ouagadougou, Burkina Faso

    X
  • Jefrey Lizardo,

    Affiliation: Center for Social Management, Technological Institute of Santo Domingo, Santo Domingo, Dominican Republic

    X
  • Mwele Malecela,

    Affiliation: National Institute of Medical Research, Dar es Salaam, Tanzania

    X
  • Godfrey Mubyazi,

    Affiliation: National Institute of Medical Research, Dar es Salaam, Tanzania

    X
  • P. Abdoulaye Nitièma,

    Affiliation: Department of Evaluation, Ministry of Health, Ouagadougou, Burkina Faso

    X
  • Reda M. R. Ramzy,

    Affiliation: Research & Training Center on Vectors of Diseases, Ain Shams University, Cairo, Egypt

    X
  • Thomas G. Streit,

    Affiliation: Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, United States of America

    X
  • Aaron Wallace,

    Affiliation: Lymphatic Filariasis Support Center, Emory University, Atlanta, Georgia, United States of America

    X
  • Molly A. Brady,

    Affiliation: Lymphatic Filariasis Support Center, Emory University, Atlanta, Georgia, United States of America

    X
  • Richard Rheingans,

    Affiliation: Lymphatic Filariasis Support Center, Emory University, Atlanta, Georgia, United States of America

    X
  • Eric A. Ottesen,

    Affiliation: Lymphatic Filariasis Support Center, Emory University, Atlanta, Georgia, United States of America

    X
  • Anne C. Haddix

    Affiliation: Lymphatic Filariasis Support Center, Emory University, Atlanta, Georgia, United States of America

    X
  • Published: October 31, 2007
  • DOI: 10.1371/journal.pntd.0000067

About the Authors

Ann S. Goldman
Department of Epidemiology and Biostatistics, The George Washington School of Public Health and Health Services, Washington, DC, United States of America
Victoria H. Guisinger, Sanjat Kanjilal, Aaron Wallace, Molly A. Brady, Richard Rheingans, Eric A. Ottesen, Anne C. Haddix
Lymphatic Filariasis Support Center, Emory University, Atlanta, Georgia, United States of America
Moses Aikins, Bertha Garshong, John Gyapong
Health Research Unit, Ghana Health Service, Accra, Ghana
Maria Lourdes E. Amarillo
Department of Clinical Epidemiology, College of Medicine, University of the Philippines, Manila, The Philippines
Vicente Y. Belizario
Department of Parasitology, College of Public Health, University of the Philippines, Manila, The Philippines
Conrad Kabali, Mwele Malecela, Godfrey Mubyazi
National Institute of Medical Research, Dar es Salaam, Tanzania
Hussein A. Kamal
Ministry of Health & Population, Cairo, Egypt
Dominique Kyelem
Lymphatic Filariasis Program, Ministry of Health, Ouagadougou, Burkina Faso
Jefrey Lizardo
Center for Social Management, Technological Institute of Santo Domingo, Santo Domingo, Dominican Republic
P. Abdoulaye Nitièma
Department of Evaluation, Ministry of Health, Ouagadougou, Burkina Faso
Reda M. R. Ramzy
Research & Training Center on Vectors of Diseases, Ain Shams University, Cairo, Egypt
Thomas G. Streit
Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, United States of America

Corresponding Author

Email: sphasg@gwumc.edu

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: BG. Performed the experiments: BG. Analyzed the data: BG. Wrote the paper: EO VG MB. Participated in the study design and its coordination, data collection and analysis: ASG VHG MA MLEA VYB BG JG CK HAK SK DK JL MM GM AN RMRR TGS AW MAB RR EAO ACH.